Regulus Therapeutics Inc (NASDAQ:RGLS)

0.6902
Delayed Data
As of 4:00pm ET
 -0.0198 / -2.79%
Today’s Change
0.61
Today|||52-Week Range
1.52
-33.63%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.71
Today’s open0.70
Day’s range0.67 - 0.73
Volume204,877
Average volume (3 months)404,700
Market cap$74.8M
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+38.06%
Earnings growth (this year)+41.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.97%
P/E ratioNM
Price/Sales1,086.67
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-1.49-9.09%
GTXIGTX Inc-0.29-1.50%
ZFGNZafgen Inc+0.42+5.97%
MEIPMEI Pharma Inc+0.25+5.90%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$72.0K
Annual profit (last year)-$71.9M
Net profit margin-99,868.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts